| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |